Breast cancers (BC) remain the most lethal malignancies amongst women. Subtype
heterogeneity and aggressive invasion are believed to be major contributors for poor …

Breast cancer (BC) is the most common malignancy in women. Particular subtypes with
aggressive behavior are major contributors to poor outcomes. Triple‑negative breast cancer …

Tumor cells release nucleic acid-containing proinflammatory complexes, termed nucleic
acid-containing damage-associated molecular patterns (NA DAMPs), passively upon death …

Breast cancer (BC) is the most common malignancy in women. Particular subtypes with
aggressive behavior are major contributors to poor outcomes. Triple-negative breast cancer …

Triple negative breast cancer (TNBC) is characterized by a lack of estrogen receptor,
progesterone receptor, and HER2. Patients with TNBC therefore cannot benefit from …

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks the expression
of 3 cell receptors--the estrogen receptor (ER), progesterone receptor (PR) and epidermal …

The high morbidity associated with triple negative breast cancers (TNBCs) is directly related
to its high risk of recurrence. TNBC recurrence is often invasive-leading to its metastasis …

Breast cancer represents the most frequently diagnosed malignancy among women with
10%–20% of all cases involving the deadliest of all subtypes, triple-negative breast cancer …

Triple-negative breast cancer (TNBC) is an aggressive disease that is unsusceptible to most
current targeted or hormonal therapies because it lacks expression of the three receptors …

Simple Summary Breast cancer that spreads to other parts of the body, known as metastatic
breast cancer, is a serious and life-threatening condition, leading to decreased survival …